English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52808711    線上人數 :  594
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 791-800 / 881 (共89頁)
<< < 75 76 77 78 79 80 81 82 83 84 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國家衛生研究院 2008-12 Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH
國立政治大學 2008-12 Teachers’ perceptions of the dimensions and implementation of technology leadership of principals in Taiwanese elementary schools Chang, I.;秦夢群;Hsu, C.; Chang, I.;Chin, J.M.;Hsu, C.
元智大學 2008-05 線上遊戲設計: 分析架構與個案探討 邱昭彰; Jen, E F; Hsu, C.
國家衛生研究院 2008-03 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Chao, TY; Liu, TW; Cheng, AL; Chen, PJ
國立臺灣大學 2008-03 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial. Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ
國立臺灣大學 2008-03 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by international prognostic scoring system, cytogenetic and genetic studies. Huang, TC; Ko, BS; Hsu, C; Chen, CY; Tsay, W; Tang, JL; Huang, SY; Yao, M; Chen, YC; Shen, MC; Wang, CH; Tien, HF
國家衛生研究院 2008 Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment Hsu, C;Chen, LT;Chao, Y;Fan, HH;Shen, YC;Cheng, AL
臺北醫學大學 2008 Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. 鄭建睿; Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
臺大學術典藏 2008 Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C
臺大學術典藏 2008 Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers Hsu C.; JIN-YUAN SHIH; Yang C.-H.; Yu C.-J.; Lo Y.; Chen J.-P.

顯示項目 791-800 / 881 (共89頁)
<< < 75 76 77 78 79 80 81 82 83 84 > >>
每頁顯示[10|25|50]項目